Abstract Achieving pain relief and improving the quality of life are the main targets of treatment for patients with chronic pancreatitis. The use of total pancreatectomy to treat chronic pancreatitis is a radical and in some ways ideal strategy. However, total pancreatectomy is associated with severe diabetic control problems. Total pancreatectomy with islet autotransplantation can relieve severe pain and prevent the development of postsurgical diabetes. With islet autotransplantation, patients with chronic pancreatitis receive their own islet cells and therefore do not require immunosuppressive therapy. In the future, total pancreatectomy with islet autotransplantation may be considered a treatment option for chronic pancreatitis patients.
Introduction
Chronic pancreatitis is a benign inflammatory disease characterized by fibrosis and destruction of the entire pancreas leading to irreversible and severe damage of both exocrine and endocrine functions [1] [2] [3] [4] [5] . The inflammation causes intractable abdominal pain. The purpose of surgical treatment to treat chronic pancreatitis is pain management [6] . Several surgical procedures for the treatment of pain associated with chronic pancreatitis have been proposed, including drainage procedures such as the PartingtonRochelle procedure and resection procedures such as pancreaticoduodenectomy, distal pancreatectomy and total pancreatectomy [7] [8] [9] [10] [11] . Resection procedures, particularly total pancreatectomy, can cause severe and permanent pancreatic endocrine and exocrine insufficiency. Total pancreatectomy with islet cell autotransplantation to treat chronic pancreatitis was first performed at the University of Minnesota in 1977 [12] . Since then, more than 500 islet autotransplantations with near-total or total pancreatectomy have been performed in patients with chronic pancreatitis [13] . This treatment strategy, which includes a combination of surgical procedures and transplantation, has the potential to be the ideal therapy for resolving the unbearable abdominal pain associated with chronic pancreatitis without causing permanent pancreatic endocrine or exocrine insufficiency (Table 1) .
Chronic pancreatitis
Severe recurrent abdominal pain is a common and frequently debilitating symptom in patients with chronic pancreatitis and significantly affects the quality of life of patients with this disease [14] [15] [16] . The main cause of abdominal pain in patients with chronic pancreatitis is elevated pressure in the pancreatic ducts or pancreatic parenchyma caused by obstruction of the pancreatic ducts [6] . Surgical drainage and endoscopic therapy are used to decompress the pancreatic ducts to achieve pain relief. However, recent studies have found that severe pain is also caused by nerve injury and neuroimmune interactions between neuronal processes and chronic inflammation [17, 18] .
Cahen et al. [19] reported in a randomized trial that surgical drainage procedures are more effective than
Department of Surgery, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan e-mail: tkuroki-gi@umin.ac.jp endoscopic treatments in treating patients with obstruction of the pancreatic ducts due to chronic pancreatitis. On the other hand, the choice of surgical methods used in various kinds of surgical procedures is important. Strate et al. [20] reported that, in their study, there were no differences between radical resection (pylorus-preserving pancreatoduodenectomy) and the organ-sparing extended drainage procedure (Frey procedure) with respect to quality of life, pain control and the exocrine and endocrine functions after long-term follow-up. Total pancreatectomy is a radical and in some ways ideal treatment option, because this approach aims to completely remove the entire pancreas affected by chronic pancreatitis. Moreover, duodenum-preserving total pancreatectomy is the best procedure for performing resection of the entire pancreatic parenchyma. However, it is well known that the duodenum-preserving method is associated with duodenal ischemia caused by interruption of the pancreaticoduodenal vascular arcade [7] . Although Table 1 Comparison of reults of total pancreatectomy with islet cell autotransplantation for chronic pancreatitis performing total pancreatectomy is challenging and the procedure is associated with high morbidity and mortality rates, recent reports comparing total pancreatectomy and pancreaticoduodenectomy demonstrate comparable outcomes [21, 22] . In addition, total pancreatectomy has an advantage over pancreatic resection procedures in that there is no potential for pancreatic fistula development, which is typically a lethal complication. However, patients undergoing total pancreatectomy often contract the brittle form of diabetes, in which hyperglycemia and hypoglycemia are particularly difficult to control [23, 24] . Chronic pancreatitis patients undergoing total pancreatectomy are candidates for islet transplantation [25] [26] [27] [28] [29] [30] 
Islet autotransplantation
After performing excision of the entire pancreas, the main pancreatic duct is cannulated and the pancreatic parenchyma is distended with collagenase and digested. Islet cells are liberated from the surrounding tissue, then isolated islet cells are infused and transplanted into the liver via the portal vein.
The purpose of islet autotransplantation following total pancreatectomy is to prevent the development of postsurgical diabetes. Therefore, preoperative tests of glycemic control and the islet function, including glucose tolerance tests and serum hemoglobin A1c level measurement, are important for determining the indications for islet autotransplantation following total pancreatectomy [25] . Patients who show normal results in preoperative testing of glycemic control and islet function can be considered for islet autotransplantation following total pancreatectomy. Ultimately, the decision to perform islet autotransplantation following total pancreatectomy should be made only after multidisciplinary discussions are held among the pancreatic surgeon, a diabetologist, a gastroenterologist, a pain specialist and a medical psychologist [25] .
Determining the ideal timing for total pancreatectomy with islet autotransplantation in patients with chronic pancreatitis is important to achieve better quality of life. Kobayashi et al. [31] . reported that the degree of pancreatic fibrosis and acinar atrophy is inversely correlated with islet yield in pediatric patients with chronic pancreatitis and suggested that total pancreatectomy with islet autotransplantation should be considered early in the course of chronic pancreatitis. In another report, the same Minnesota group [32] found that pancreatic biopsies of tissue obtained from three young patients who underwent total pancreatectomy with islet autotransplantation for the management of chronic pancreatitis provided unique evidence of islet neogenesis from pancreatic ductal progenitor cells. These findings suggest that pancreatic ductal precursors may play an important role as a source of islet neogenesis in patients with chronic pancreatitis. Therefore, while chronic pancreatitis leads to severe destructive inflammation with irreversible ductal and parenchymal destruction, islet neogenesis from ductal precursors can result from islet autotransplantation in chronic pancreatitis patients. Takita et al. [33] reported that excellent glycemic control was observed in both early-stage and advancedstage chronic pancreatitis groups, who underwent total pancreatectomy with islet autotransplantation. Interestingly, the advanced-stage chronic pancreatitis group exhibited larger islet sizes than the early-stage group, even though the total islet yield in that group was lower.
On the other hand, predictive factors associated with successful islet autotransplantation following total pancreatectomy are important. Several reports have suggested that the number of islets transplanted is a key factor in transplant success. Sutherland et al. [29] reported that insulin independence was observed 1 year following autotransplantation in 63 % of patients who received greater than 5,000 IE/kg. Bellin et al. [34] reported that an islet yield greater than 2,000 IE/kg is an important predictor of insulin independence. White et al. [35] reported that insulin independence appears to be related to the number of islet cells transplanted ([3,000 IEQ/kg). On the other hand, Ahmad et al. [36] reported that transplantation of more than 6,635 IEQ/kg is associated with the possibility of becoming insulin independent, and that patients with increased body mass indices are less likely to benefit from total pancreatectomy with islet autotransplantation and should be counseled to lose weight before undergoing islet autotransplantation. In this report, 40 % of 45 chronic pancreatitis patients who underwent total pancreatectomy with autotransplantation were insulin-free after a mean follow-up of 18 months. In another large series, the Minnesota group reported that 39 % of 112 chronic pancreatitis patients who underwent islet autotransplantation remained insulin independent [37] .
The aim of total pancreatectomy in the treatment of chronic pancreatitis is to relieve pain and restore quality of life [38] . It is difficult to quantitatively evaluate the pain that a patient suffers after undergoing islet autotransplantation. The Cincinnati group [36] reported standardized narcotic usage by conversion to morphine equivalents and found a marked reduction in postoperative morphine equivalents (mean 90 mg) after total pancreatectomy compared with preoperative morphine equivalents (mean 206 mg). In addition, 58 % of the chronic pancreatitis patients in that study exhibited notable reductions in chronic abdominal pain, as demonstrated by narcotic independence at the last follow-up. The Cincinnati series [39] also reported significant improvements in quality of life using a validated standard assessment questionnaire (SF-36). The Minnesota group [37] reported that 72 % of patients exhibit a resolved or improved pain status after undergoing total pancreatectomy. Morgan et al. [40] . reported that pain control and quality of life after total pancreatectomy with islet autotransplantation for chronic pancreatitis are measured using daily oral morphine equivalents and the SF-12 questionnaire. On the other hand, Lieb et al. [17] reported pain relief following the modified Puestow operation and lateral pancreaticojejunostomy, which are the most common surgical procedures for treating chronic pancreatitis, in a review article. They showed that short-term pain relief is observed in approximately 80 % of patients, while long-term pain relief (over 5 years) is observed in only 50 % of patients.
Conclusion
Surgical drainage procedures and partial pancreatic resection have been recognized as first-line surgical choices before total pancreatectomy in most institutions. Indications for total pancreatectomy include small duct-type chronic pancreatitis, diffuse glandular involvement and intractable pain after drainage and resection. Total pancreatectomy alone will result in diabetes; therefore, it should be accompanied by islet autotransplantation whenever possible to prevent or minimize this development. In islet autotransplantation, patients with chronic pancreatitis receive their own islet cells and therefore do not require immunosuppressive therapy. In the future, total pancreatectomy with islet autotransplantation may be considered the goldstandard treatment for treating chronic pancreatitis patients.
